MKI67 and pituitary gland adenoma: However, some scholars (4, 5) preferred to regard an aggressive adenoma as a separated type that displays more aggressive clinical progression despite of the tumor size and should be diagnosed based on the elevated immunoreactivity of Ki-67 and P53 over more “benign” types of pituitary adenoma using tissue immunohistochemistry.